IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
about
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancerCX3CR1 delineates temporally and functionally distinct subsets of myeloid-derived suppressor cells in a mouse model of ovarian cancerCytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancerIn situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.Flagellin treatment prevents increased susceptibility to systemic bacterial infection after injury by inhibiting anti-inflammatory IL-10+ IL-12- neutrophil polarization.The Role of Myeloid-Derived Suppressor Cells in Viral Infection.The Unique Molecular and Cellular Microenvironment of Ovarian CancerHepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.The prognostic significance of CD11b+CX3CR1+ monocytes in patients with newly diagnosed diffuse large B-cell lymphoma.PRKCI promotes immune suppression in ovarian cancer.Revisiting ovarian cancer microenvironment: a friend or a foe?Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.Immunotherapy for ovarian cancer: what are the targets of the future?Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System.
P2860
Q30408322-9F081793-C892-41DF-96F1-C4D28FFF75E1Q33565624-CEF9320C-BBAC-430A-89B4-A220C4B504B5Q33569771-860319AA-D1D0-4B72-8E8F-E9D5809A38A0Q34043804-F4C1B544-36F9-4C05-BF71-CF11F00FCAD6Q34414289-BD4B8392-4656-4A67-8A62-0F908008044BQ35604189-17F97271-27A8-45A9-B5ED-5538B3AF7F16Q36649674-6234297D-8438-46BE-AC39-8297F32C52A0Q37484450-B0F05D7E-035A-4260-AEF6-B3B7573DF056Q38774994-48F0FE91-4339-45C4-B9B1-DF984076AB1DQ39169603-193CE6D8-AEE9-4D01-9BDA-1292CE2122BBQ40686250-508393B9-C13A-4955-9DAA-23481E5C9663Q47151518-9968C17A-31BC-453F-8299-A21E269EA24DQ47154650-8D4D0AD6-0C49-42BB-9733-4F5F89670583Q47773956-573C7B7D-4450-4689-A443-BDC0876E9DEBQ48294132-BC2D4438-937B-419E-867B-7B4688BADBB0Q48489326-82293C69-1238-4F30-9FA4-A4D5571B9AE3Q55378779-AF3DF306-F524-47E1-875D-E81A0033C561
P2860
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
@ast
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
@en
type
label
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
@ast
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
@en
prefLabel
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
@ast
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
@en
P2093
P2860
P356
P1476
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.
@en
P2093
Brent Berwin
Edward M Usherwood
Katelyn T Byrne
Kevin M Hart
Michael J Molloy
P2860
P356
10.3389/FIMMU.2011.00029
P577
2011-07-21T00:00:00Z